(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine

C97H143N23O7 — CID 158998990

IUPAC(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine
SMILESCCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)CO4.CCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)O4.CCCCn1c(N)nc2ccc(OCCN(C)C)cc21.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)CO3.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)O3.CCCCn1c(N)nc2ccc3c(c21)CC(CO)O3
InChIInChI=1S/C18H26N4O.C17H24N4O.C17H26N4O.C16H24N4O.C15H24N4O.C14H19N3O2/c1-4-12-8-19-18-20-15-5-6-16-14(17(15)22(18)10-12)7-13(11-23-16)9-21(2)3;1-4-11-8-18-17-19-14-5-6-15-13(16(14)21(17)9-11)7-12(22-15)10-20(2)3;1-4-5-8-21-16-13-9-12(10-20(2)3)11-22-15(13)7-6-14(16)19-17(21)18;1-4-5-8-20-15-12-9-11(10-19(2)3)21-14(12)7-6-13(15)18-16(20)17;1-4-5-8-19-14-11-12(20-10-9-18(2)3)6-7-13(14)17-15(19)16;1-2-3-6-17-13-10-7-9(8-18)19-12(10)5-4-11(13)16-14(17)15/h5-6,12-13H,4,7-11H2,1-3H3,(H,19,20);5-6,11-12H,4,7-10H2,1-3H3,(H,18,19);6-7,12H,4-5,8-11H2,1-3H3,(H2,18,19);6-7,11H,4-5,8-10H2,1-3H3,(H2,17,18);6-7,11H,4-5,8-10H2,1-3H3,(H2,16,17);4-5,9,18H,2-3,6-8H2,1H3,(H2,15,16)
InChIKeyJRCLBWKDTXKXMJ-UHFFFAOYSA-N
MW1743.36 g/mol
LogP13.84
Rot. Bonds27

About (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine

(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine (PubChem CID 158998990) has the molecular formula C97H143N23O7 and a molecular weight of 1743.36 g/mol. Its IUPAC name is (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine.

Molecular Properties

Compound Name(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine
PubChem CID158998990
Molecular FormulaC97H143N23O7
Molecular Weight1743.36 g/mol
Exact Mass1742.15
IUPAC Name(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine
SMILESCCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)CO4.CCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)O4.CCCCn1c(N)nc2ccc(OCCN(C)C)cc21.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)CO3.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)O3.CCCCn1c(N)nc2ccc3c(c21)CC(CO)O3
InChIInChI=1S/C18H26N4O.C17H24N4O.C17H26N4O.C16H24N4O.C15H24N4O.C14H19N3O2/c1-4-12-8-19-18-20-15-5-6-16-14(17(15)22(18)10-12)7-13(11-23-16)9-21(2)3;1-4-11-8-18-17-19-14-5-6-15-13(16(14)21(17)9-11)7-12(22-15)10-20(2)3;1-4-5-8-21-16-13-9-12(10-20(2)3)11-22-15(13)7-6-14(16)19-17(21)18;1-4-5-8-20-15-12-9-11(10-19(2)3)21-14(12)7-6-13(15)18-16(20)17;1-4-5-8-19-14-11-12(20-10-9-18(2)3)6-7-13(14)17-15(19)16;1-2-3-6-17-13-10-7-9(8-18)19-12(10)5-4-11(13)16-14(17)15/h5-6,12-13H,4,7-11H2,1-3H3,(H,19,20);5-6,11-12H,4,7-10H2,1-3H3,(H,18,19);6-7,12H,4-5,8-11H2,1-3H3,(H2,18,19);6-7,11H,4-5,8-10H2,1-3H3,(H2,17,18);6-7,11H,4-5,8-10H2,1-3H3,(H2,16,17);4-5,9,18H,2-3,6-8H2,1H3,(H2,15,16)
InChIKeyJRCLBWKDTXKXMJ-UHFFFAOYSA-N
XLogP13.84
TPSA326.87 Ų
H-Bond Donors7
H-Bond Acceptors30
Rotatable Bonds27
Heavy Atoms127
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001743.36
LogP ≤ 513.84
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1030

Analyze (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US11834453, Example 107
CID 167318541
US11834453, Example 194
CID 167318808
US11834453, Example 197
CID 167318830
4-(6-Aminopurin-9-yl)-2-[[2-[2-[[9-[2-[2-[(6-aminopurin-9-yl)methoxy]ethylamino]ethyl]-8-[[9-[2-[2-[(6-aminopurin-9-yl)methoxy]ethylamino]ethyl]-7-(trifluoromethyl)carbazol-3-yl]methyl]carbazol-3-yl]methoxy]-7-methylcarbazol-9-yl]ethylamino]methyl]oxolane-3,4-diol
CID 139448107
3,3-difluoro-1-methylpiperidin-4-ol;5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyphenyl]quinazolin-4-amine;5-fluoro-N-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyphenyl]quinazolin-4-amine
CID 158335641
1-[[2-[5-(2-Methoxyethoxy)benzimidazol-1-yl]quinolin-8-yl]-piperidin-4-ylmethyl]pyrrolidin-3-ol
CID 22227000
1-[1-(1,3-Benzodioxol-4-ylmethyl)piperidin-4-yl]-2-[4-[2-[[4-(2-pyrrolidin-3-ylbenzimidazol-1-yl)piperidin-1-yl]methyl]-2,3-dihydro-1,4-benzodioxin-3-yl]pyrrolidin-3-yl]benzimidazole
CID 123310947
[14-[(Dimethylamino)methyl]-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl]methanol
CID 136103713
1-[4-[2-[4-Amino-2-(ethoxymethyl)-1-methylimidazo[4,5-c]quinolin-9-yl]oxypropylamino]-2-(ethoxymethyl)-1-methylimidazo[4,5-c]quinolin-9-yl]oxy-2-methylpropan-2-ol
CID 146387108
2-(Ethoxymethyl)-9-[5-[[2-(ethoxymethyl)-9-[5-[[2-(ethoxymethyl)-1-methyl-9-piperidin-4-yloxyimidazo[4,5-c]quinolin-4-yl]amino]pyrrolidin-3-yl]oxy-1-methylimidazo[4,5-c]quinolin-4-yl]amino]oxolan-3-yl]oxy-1-methylimidazo[4,5-c]quinolin-4-amine
CID 146387159
3-[[2-[2-[4-[4,7-bis[6-[3-(dimethylamino)propoxy]-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]butyl]-7-[6-[3-(dimethylamino)propoxy]-1H-benzimidazol-2-yl]-3H-benzimidazol-4-yl]-3H-benzimidazol-5-yl]oxy]-N,N-dimethylpropan-1-amine
CID 147090903
6-[2-[[4,15-Bis[(dimethylamino)methyl]-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-8-yl]methyl-methylamino]ethoxy]-4-[2-[[3-[[3-[(dimethylamino)methyl]-1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazol-7-yl]oxy]propyl-methylamino]methyl]-4-pyridinyl]-1-[3-(dimethylamino)propyl]benzimidazol-2-amine
CID 156186505

Frequently Asked Questions

What is the IUPAC name of (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine?
The IUPAC name of (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine (CID 158998990) is (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine.
What is the SMILES notation for (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine?
The canonical SMILES for (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine is CCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)CO4.CCC1CNc2nc3ccc4c(c3n2C1)CC(CN(C)C)O4.CCCCn1c(N)nc2ccc(OCCN(C)C)cc21.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)CO3.CCCCn1c(N)nc2ccc3c(c21)CC(CN(C)C)O3.CCCCn1c(N)nc2ccc3c(c21)CC(CO)O3.
What is the InChIKey of (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine?
The InChIKey is JRCLBWKDTXKXMJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H26N4O.C17H24N4O.C17H26N4O.C16H24N4O.C15H24N4O.C14H19N3O2/c1-4-12-8-19-18-20-15-5-6-16-14(17(15)22(18)10-12)7-13(11-23-16)9-21(2)3;1-4-11-8-18-17-19-14-5-6-15-13(16(14)21(17)9-11)7-12(22-15)10-20(2)3;1-4-5-8-21-16-13-9-12(10-20(2)3)11-22-15(13)7-6-14(16)19-17(21)18;1-4-5-8-20-15-12-9-11(10-19(2)3)21-14(12)7-6-13(15)18-16(20)17;1-4-5-8-19-14-11-12(20-10-9-18(2)3)6-7-13(14)17-15(19)16;1-2-3-6-17-13-10-7-9(8-18)19-12(10)5-4-11(13)16-14(17)15/h5-6,12-13H,4,7-11H2,1-3H3,(H,19,20);5-6,11-12H,4,7-10H2,1-3H3,(H,18,19);6-7,12H,4-5,8-11H2,1-3H3,(H2,18,19);6-7,11H,4-5,8-10H2,1-3H3,(H2,17,18);6-7,11H,4-5,8-10H2,1-3H3,(H2,16,17);4-5,9,18H,2-3,6-8H2,1H3,(H2,15,16).
What are the key properties of (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine?
(2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine has a molecular weight of 1743.36 g/mol, XLogP of 13.84, 27 rotatable bonds, 7 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (2-amino-1-butyl-7,8-dihydrofuro[3,2-e]benzimidazol-7-yl)methanol;1-butyl-6-[2-(dimethylamino)ethoxy]benzimidazol-2-amine;1-butyl-7-[(dimethylamino)methyl]-7,8-dihydrofuro[3,2-e]benzimidazol-2-amine;1-butyl-8-[(dimethylamino)methyl]-8,9-dihydro-7H-pyrano[3,2-e]benzimidazol-2-amine;1-(15-ethyl-6-oxa-11,13,17-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,11-tetraen-4-yl)-N,N-dimethylmethanamine;1-(14-ethyl-5-oxa-10,12,16-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,10-tetraen-4-yl)-N,N-dimethylmethanamine is sourced from PubChem (CID 158998990), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).